✦ LIBER ✦

Dosing to rash: A phase II trial of the first-line erlotinib for patients with advanced non-small-cell lung cancer an Eastern Cooperative Oncology Group Study (E3503)

✍ Scribed by Brahmer, J.R.; Lee, J.W.; Traynor, A.M.; Hidalgo, M.M.; Kolesar, J.M.; Siegfried, J.M.; Guaglianone, P.P.; Patel, J.D.; Keppen, M.D.; Schiller, J.H.

Book ID: 125439036
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 357 KB
Volume: 50
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2013.10.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Study of Erlotinib as a First

A Phase II Study of Erlotinib as a First-Line Therapy for Patients with Non—Small-Cell Lung Cancer with Favorable Clinical Predictors

✍ Dae Ho Lee; Sang-We Kim; Cheolwon Suh; Tak Yun; Heung Tae Kim; Eun Kyung Cho; Jo 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 62 KB

First-Line Single Agent Treatment With G

First-Line Single Agent Treatment With Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer: A Phase II Study

✍ Niho, S. 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 124 KB

Randomized, Placebo-Controlled, Phase II

Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy As First-Line Treatment for Advanced Non-Small-Cell Lung Cancer

✍ Mok, T. S.K.; Wu, Y.-L.; Yu, C.-J.; Zhou, C.; Chen, Y.-M.; Zhang, L.; Ignacio, J 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 151 KB

A Phase II trial of carboplatin and vind

A Phase II trial of carboplatin and vindesine in patients with non-small cell lung cancer. A Hellenic Cooperative Oncology Group study

✍ Pavlidis, Nicholas A.; Klouvas, George; Nicolaides, Costas; Karantanas, Apostolo 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 354 KB

Phase II Clinical Trial of Chemotherapy-

Phase II Clinical Trial of Chemotherapy-Naive Patients >= 70 Years of Age Treated With Erlotinib for Advanced Non-Small-Cell Lung Cancer

✍ Jackman, D. M.; Yeap, B. Y.; Lindeman, N. I.; Fidias, P.; Rabin, M. S.; Temel, J 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 134 KB

First-line erlotinib in patients with ad

First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial

✍ Siow Ming Lee; Iftekhar Khan; Sunil Upadhyay; Conrad Lewanski; Stephen Falk; Ger 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 314 KB